GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human transthyretin in complex with 3,5,6- trichloro-2-pyridinol (TC2P)

Analyse Crystal structure of human transthyretin in complex with 3,5,6… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6GRP
Type
protein
Length
232 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Transthyretin
UniProt
P02766
Ligands
F4Z, NA
Pockets
1 · best druggability 0.29

Structure

x-ray diffraction · 1 distinct chain · 6% helix, 53% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BTransthyretinprotein1166% helix, 53% strandP02766

Ligands and binding sites

  • F4Z · 3,5,6-trichloro-2-pyridinol · ligand · 4 copies · chains A, B
  • NA · Sodium ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1630.290.7415empty

Interfaces

1 interface between chains.

  • A–B · 932 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 6GRP · Crystal Structure Of Human Transthyretin in complex with 3,5,6-trichloro-2-pyridinol… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.